Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2003
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355901A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
10/29/2003EP1355889A1 Substituted triazole diamine derivatives as kinase inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355886A1 Fused heterocyclic compounds
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1214302B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
10/29/2003EP1112256B1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
10/29/2003EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452619A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
10/29/2003CN1452458A Herbicidal 5-benzyloxymethyl-1,2,-isoxazoline derivs
10/28/2003US6639082 Cycloboronate intermediates; endothelin antagonists useful, inter alia, for the treatment of hypertension.
10/28/2003US6639070 4-substituted 1,3,4-oxadiazines; herbicides
10/28/2003US6638965 Antitumor agents
10/28/2003US6638960 Use as microbicides, especially fungicides, in crop protection
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638955 Antibiotic oxazolidinone derivatives
10/28/2003US6638953 Indole derivatives as 5-HT receptor antagonist
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638937 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638930 Morpholine and thiomorpholine tachykinin receptor antagonists
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2249786C Difluoro statone analogs
10/28/2003CA2233792C Process to chloroketones using oxazolines
10/28/2003CA2104268C Preparation of imidazoles
10/23/2003WO2003087095A1 Quinolinone derivatives
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087077A1 A semi-synthetic process for the preparation of n­ debenzoylpaclitaxel
10/23/2003WO2003087060A1 Fredericamycin derivatives
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2002081483A3 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003WO2001036048A8 Phorboxazole derivatives for treating cancer
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199565 Gastrin and cholecystokinin receptor ligands(II)
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199556 beta3- adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof
10/23/2003US20030199553 Antidiabetic agents
10/23/2003US20030199534 Kinase inhibitors
10/23/2003US20030199526 Pyrimidine-based compounds useful as GSK-3 inhibitors
10/23/2003US20030199525 Kinase inhibitors
10/23/2003US20030199516 Methods of treating infection by drug resistant bacteria
10/23/2003US20030199513 Cinnoline derivatives and use as medicine
10/23/2003US20030199493 A dibenzofuranazepine derivatives for use as therapeutic treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, stroke, cerebral trauma
10/23/2003US20030199479 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199046 Processes and intermediates useful in preparing beta3-adrenergic receptor agonists
10/23/2003CA2484261A1 Piperidine derivatives having ccr3 antagonism
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/22/2003EP1354879A1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1353917A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353911A1 Antiviral agents
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1254129B1 Method for the preparation of 5-cyanophthalide
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1087967B1 1,3-oxazoline and 1,3-thiazoline derivatives, method for producing the same and their use as pesticides
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003EP0980368B1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1451003A Process for the preparation of a piperazine derivative
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125065C Benzo[g] quinoline derivatives
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2074155C Herbicidal 4-acyl-5-arylisoxazoles
10/21/2003CA2049733C 6,7-dihydro-3-phenyl-1,2-benzisoxazol-4(5h)-ones and -ols, a process for their preparation and their use as medicaments
10/16/2003WO2003085005A1 Photopolymerizable composition
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084953A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084535A1 Antidiabetic agents
1 ... 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 ... 647